Arnaud Godin
Biographic Data
| ID | 7198037 |
|---|---|
| NAME | Arnaud Godin |
| GIVEN NAMES | Arnaud |
| FAMILY NAME | Godin |
| SIGNATURE | GODIN A |
| AFFILIATIONS | McGill University |
| ORCID | 0000-0002-5823-3961 |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Canada’s provincial Covid-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses
Public health interventions, priority populations, and the impact of Covid-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study
HCV treatment scale-up among all PWID will be required to eliminate HCV in high-incidence and prevalence settings. Achieving elimination by 2030 will entail concerted efforts to restore and enhance pre-pandemic levels of HCV prevention and care
Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030
Despite ongoing transmission risks, HCV incidence rebounds slowly after 2030 under pre-2020 testing and treatment levels. This is heightened by maintaining high-coverage harm reduction interventions. Overall, sustaining elimination would require considerably less effort than achieving it
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada
No prominent works on this page.
Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: A model-based cost-effectiveness analysis
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030
Despite ongoing transmission risks, HCV incidence rebounds slowly after 2030 under pre-2020 testing and treatment levels. This is heightened by maintaining high-coverage harm reduction interventions. Overall, sustaining elimination would require considerably less effort than achieving it
The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada
Public health interventions, priority populations, and the impact of Covid-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study
HCV treatment scale-up among all PWID will be required to eliminate HCV in high-incidence and prevalence settings. Achieving elimination by 2030 will entail concerted efforts to restore and enhance pre-pandemic levels of HCV prevention and care
Canada’s provincial Covid-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses
Medicine (5 works) · Virology (5 works) · Hepatitis C (4 works) · Hepatitis C virus research (4 works) · Psychiatry (4 works) · HIV, Drug Use, Sexual Risk (3 works) · Psychological intervention (3 works) · Computer Science (2 works) · Demography (2 works) · Demography (2 works)